1YZ1

crystal structure of human translationally controlled tumour associated protein

• Total interactions analyzed: 6
• Total true interactions: 5
• Strongest Interaction:
  • Chains: B-C
  • Int. Res.: 41
  • Norm. En. per Res.: -2.2462
• Hub Node: A(3)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
A-B	0.0	0.0	-0.0173	-0.0173	2	0	0	11	0	0	0
A-C	0.0	0.9305	-19.0047	-18.0742	36	0	0	1251	2	20	28
A-D	0.0	3.8975	-71.3621	-67.4646	40	1	0	2901	0	12	5
B-C	-34.8126	22.1067	-79.3865	-92.0924	41	4	0	2974	0	13	7
B-D	0.0	-6.6453	-25.3494	-31.9947	22	0	0	937	0	15	15

Interface residues

• A-B: MET140B, PRO142A
• A-C: ASN141A, ASN141C, ASP143A, ASP143C, ASP94A, ASP94C, GLN106A, GLU104A, GLU105A, GLU105C, GLY101A, GLY101C, GLY144A, HIS10A, HIS10C, ILE8A, ILE8C, ILE99A, ILE99C, LEU103A, LEU7A, LYS100A, LYS102A, LYS102C, LYS90C, LYS93C, LYS97A, LYS97C, PRO108A, PRO142A, PRO142C, SER98A, SER98C, SER9A, SER9C, TYR95C
• A-D: ALA87A, ALA87D, ASN128D, ASN131A, ASN131D, ASP150A, ASP150D, GLN133A, GLN133D, GLN79A, GLN79D, GLU80A, GLU80D, GLU86A, GLU86D, GLY155A, GLY155D, LEU149D, LYS130A, LYS130D, LYS85A, LYS85D, PHE129A, PHE129D, PHE134A, PHE134D, PHE135A, PHE135D, PHE83A, PHE83D, SER82A, SER82D, THR81A, THR81D, THR84A, THR84D, TYR132A, TYR132D, TYR151A, TYR151D
• B-C: ALA87B, ALA87C, ASN128B, ASN128C, ASN131B, ASN131C, ASP150C, GLN133B, GLN133C, GLN79B, GLN79C, GLU80B, GLU80C, GLU86B, GLU86C, LEU149B, LEU149C, LYS130B, LYS130C, LYS85B, LYS85C, PHE129B, PHE129C, PHE134B, PHE134C, PHE135B, PHE135C, PHE83B, PHE83C, SER82B, SER82C, THR81B, THR81C, THR84B, THR84C, TYR132B, TYR132C, TYR151C, TYR88B, TYR88C, VAL73C
• B-D: ARG5B, ASN139B, ASN139D, ASN141B, ASN141D, ASP11B, ASP11D, ASP143D, GLN79D, GLU138D, GLU168B, GLU170B, GLY137D, HIS10B, HIS77D, ILE136D, ILE8B, LEU7B, LYS102B, MET140D, PRO142D, SER9B